BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33790969)

  • 1. Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients.
    Liu J; Chen Z; Li W
    J Oncol; 2021; 2021():6676537. PubMed ID: 33790969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma.
    Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X
    BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and verification of a prognostic risk score model based on immune genes for hepatocellular carcinoma in an Asian population.
    Wang Y; Feng Z; Zhang Y; Zhang Y
    Transl Cancer Res; 2023 Oct; 12(10):2806-2822. PubMed ID: 37969383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma.
    Ouyang G; Yi B; Pan G; Chen X
    Cancer Cell Int; 2020; 20():207. PubMed ID: 32514252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
    Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
    BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma.
    Xu D; Wang Y; Wu J; Zhang Y; Liu Z; Chen Y; Zheng J
    Front Cell Dev Biol; 2021; 9():686664. PubMed ID: 34631695
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma.
    Yang Y; Wu G; Li Q; Zheng Y; Liu M; Zhou L; Chen Z; Wang Y; Guo Q; Ji R; Zhou Y
    Front Mol Biosci; 2021; 8():690206. PubMed ID: 34262941
    [No Abstract]   [Full Text] [Related]  

  • 10. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
    Li W; Lu J; Ma Z; Zhao J; Liu J
    Front Genet; 2019; 10():1323. PubMed ID: 32010188
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma.
    Zhu Z; Song M; Li W; Li M; Chen S; Chen B
    Front Oncol; 2021; 11():695001. PubMed ID: 34616672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
    Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
    Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
    Liu GM; Zeng HD; Zhang CY; Xu JW
    Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
    Li X; Lin J; Pan Y; Cui P; Xia J
    Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma.
    Shang BB; Chen J; Wang ZG; Liu H
    PeerJ; 2021; 9():e12315. PubMed ID: 34754620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
    Lin Z; Xu Q; Miao D; Yu F
    Front Oncol; 2021; 11():644416. PubMed ID: 33828988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel machine learning derived RNA-binding protein gene-based score system predicts prognosis of hepatocellular carcinoma patients.
    Zhang Q; Zhang Y; Guo Y; Tang H; Li M; Liu L
    PeerJ; 2021; 9():e12572. PubMed ID: 35036125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.